資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://tkuir.lib.tku.edu.tw/dspace/handle/987654321/122692
|
| 題名: | Quality of life changes in patients undergoing treatment for hepatocellular carcinoma |
| 作者: | Chie, Wei-Chu;Yu, Fang;Li, Mengqian;Baccaglini, Lorena;Blazeby, Jane M;Hsiao, Chin-Fu;Chiu, Herng-Chia;Poon, Ronnie T;Mikoshiba, Naoko;Gillian, Al-Kadhimi;Heaton, Nigel;Calara, Jozer;Collins, Peter;Caddick, Katharine;Costantini, Anna;Vilgrain, Valerie;Chiang, Chieh |
| 關鍵詞: | Quality of life;Asian;Treatment;Hepatocellular;Carcinoma |
| 日期: | 2015-05-06 |
| 上傳時間: | 2022-05-09 12:10:22 (UTC+8) |
| 摘要: | Purpose
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. One of the primary treatment goals for incurable advanced cases is to prolong quality of life (QoL). Thus, to determine which HCC therapies may be linked to a more favorable QoL, we assessed the association between QoL changes and different treatments in HCC patients.
Methods
We analyzed a non-randomized multicenter longitudinal study, which included 171 patients treated with surgery (n = 53), ablation (n = 53) or embolization (n = 65) from seven centers: four Asian and three European sites. All participants completed the EORTC QLQ-C30 and QLQ-HCC18 questionnaires before and after treatment. Propensity scores were calculated and used in addition to race for adjustment in the logistic regression model to account for the confounding effects of patient characteristics including age, gender, race, employment, living with family, at least one comorbid condition, years since diagnosis, prior treatment history, BCLC stage, Child–Pugh grade, cirrhosis, bilirubin levels and QoL score before treatment.
Results
After adjustment for confounders, patients tended to have higher odds of QoL deterioration when treated with ablation versus embolization (dyspnea: p = 0.019; appetite loss: p = 0.018; body image: p = 0.035) or ablation versus surgery (dyspnea: p = 0.099; appetite loss: p = 0.100; body image: p = 0.038).
Conclusions
There were significant differences in QoL deterioration across different treatment groups. This information may assist patients and providers when selecting patient-centered treatment approaches for HCC. |
| 關聯: | Quality of Life Research 24(10), 2499-2506 |
| DOI: | 10.1007/s11136-015-0985-8 |
| 顯示於類別: | [應用數學與數據科學學系] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 79 | 檢視/開啟 |
|
在機構典藏中所有的資料項目都受到原著作權保護.
|
